Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | IMVT |
---|---|---|
09:32 ET | 3864 | 28.4001 |
09:34 ET | 7751 | 28.59 |
09:36 ET | 1931 | 28.53 |
09:48 ET | 300 | 28.5 |
09:50 ET | 1456 | 28.525 |
09:52 ET | 1596 | 28.33 |
09:54 ET | 1100 | 28.425 |
09:56 ET | 1852 | 28.51 |
09:59 ET | 2265 | 28.49 |
10:03 ET | 380 | 28.41 |
10:06 ET | 501 | 28.5068 |
10:08 ET | 2400 | 28.45 |
10:10 ET | 600 | 28.38 |
10:12 ET | 2900 | 28.455 |
10:14 ET | 850 | 28.49 |
10:15 ET | 850 | 28.41 |
10:17 ET | 100 | 28.31 |
10:19 ET | 100 | 28.31 |
10:21 ET | 600 | 28.36 |
10:24 ET | 1300 | 28.45 |
10:28 ET | 100 | 28.39 |
10:30 ET | 6040 | 28.435 |
10:33 ET | 1500 | 28.32 |
10:35 ET | 5605 | 28.28 |
10:37 ET | 600 | 28.28 |
10:39 ET | 700 | 28.31 |
10:42 ET | 1800 | 28.38 |
10:44 ET | 800 | 28.4 |
10:46 ET | 3444 | 28.44 |
10:48 ET | 600 | 28.43 |
10:51 ET | 341 | 28.415 |
10:53 ET | 4219 | 28.35 |
10:55 ET | 400 | 28.32 |
10:57 ET | 3090 | 28.31 |
11:00 ET | 550 | 28.26 |
11:02 ET | 3647 | 28.2 |
11:04 ET | 1800 | 28.145 |
11:06 ET | 2043 | 28.145 |
11:08 ET | 3873 | 28.12 |
11:09 ET | 300 | 28.135 |
11:11 ET | 4676 | 28.05 |
11:13 ET | 1500 | 28.04 |
11:15 ET | 700 | 28.03 |
11:18 ET | 1786 | 28.045 |
11:20 ET | 1100 | 28.04 |
11:22 ET | 2700 | 28.03 |
11:24 ET | 500 | 28.06 |
11:26 ET | 1300 | 28 |
11:27 ET | 1200 | 27.94 |
11:29 ET | 3870 | 28.06 |
11:31 ET | 175 | 28.0384 |
11:33 ET | 1200 | 28.12 |
11:36 ET | 2447 | 28.11 |
11:38 ET | 20404 | 28.08 |
11:40 ET | 400 | 28.025 |
11:42 ET | 1300 | 28.105 |
11:45 ET | 200 | 28.11 |
11:47 ET | 1800 | 28.155 |
11:49 ET | 645 | 28.15 |
11:51 ET | 300 | 28.155 |
11:54 ET | 100 | 28.15 |
11:56 ET | 10420 | 28.115 |
11:58 ET | 200 | 28.115 |
12:00 ET | 400 | 28.14 |
12:02 ET | 900 | 28.11 |
12:03 ET | 1072 | 28.15 |
12:05 ET | 400 | 28.115 |
12:07 ET | 100 | 28.115 |
12:09 ET | 2057 | 28.13 |
12:12 ET | 700 | 28.13 |
12:14 ET | 1900 | 28.12 |
12:16 ET | 1424 | 28.1 |
12:18 ET | 200 | 28.085 |
12:20 ET | 11584 | 28.1 |
12:23 ET | 400 | 28.115 |
12:25 ET | 950 | 28.09 |
12:27 ET | 200 | 28.095 |
12:30 ET | 200 | 28.095 |
12:32 ET | 1600 | 28.1 |
12:34 ET | 700 | 28.125 |
12:36 ET | 600 | 28.1 |
12:38 ET | 500 | 28.085 |
12:39 ET | 400 | 28.09 |
12:41 ET | 1111 | 28.14 |
12:48 ET | 150 | 28.1 |
12:50 ET | 700 | 28.1 |
12:52 ET | 400 | 28.11 |
12:54 ET | 1070 | 28.12 |
12:56 ET | 2985 | 28.15 |
12:57 ET | 400 | 28.135 |
12:59 ET | 800 | 28.105 |
01:01 ET | 1400 | 28.125 |
01:03 ET | 100 | 28.13 |
01:06 ET | 3883 | 28.18 |
01:08 ET | 1645 | 28.13 |
01:10 ET | 400 | 28.095 |
01:12 ET | 5655 | 28.08 |
01:14 ET | 120 | 28.08 |
01:15 ET | 2414 | 28.125 |
01:17 ET | 1500 | 28.15 |
01:19 ET | 840 | 28.14 |
01:21 ET | 3100 | 28.2 |
01:24 ET | 9268 | 28.22 |
01:26 ET | 2165 | 28.37 |
01:30 ET | 935 | 28.33 |
01:32 ET | 900 | 28.4 |
01:33 ET | 900 | 28.4 |
01:35 ET | 300 | 28.3 |
01:37 ET | 400 | 28.29 |
01:39 ET | 700 | 28.25 |
01:42 ET | 5747 | 28.31 |
01:44 ET | 6948 | 28.33 |
01:46 ET | 772 | 28.31 |
01:48 ET | 1645 | 28.3 |
01:50 ET | 2635 | 28.21 |
01:51 ET | 26904 | 28.21 |
01:53 ET | 22224 | 28.18 |
01:55 ET | 2142 | 28.265 |
01:57 ET | 2680 | 28.18 |
02:00 ET | 1285 | 28.18 |
02:02 ET | 400 | 28.1 |
02:04 ET | 300 | 28.1 |
02:06 ET | 200 | 28.1 |
02:08 ET | 1751 | 28.04 |
02:09 ET | 2175 | 28.01 |
02:11 ET | 3762 | 28.025 |
02:13 ET | 200 | 28.01 |
02:15 ET | 300 | 28.01 |
02:18 ET | 600 | 28.02 |
02:20 ET | 2353 | 28.0275 |
02:22 ET | 473 | 28 |
02:24 ET | 900 | 27.99 |
02:26 ET | 2260 | 28.01 |
02:27 ET | 1200 | 28.015 |
02:29 ET | 5369 | 28.0792 |
02:31 ET | 8941 | 28.03 |
02:33 ET | 4989 | 28.01 |
02:36 ET | 700 | 28.01 |
02:38 ET | 905 | 28 |
02:40 ET | 1346 | 28 |
02:42 ET | 2400 | 28.06 |
02:44 ET | 910 | 28.025 |
02:45 ET | 600 | 28 |
02:47 ET | 1700 | 28.07 |
02:49 ET | 100 | 28.04 |
02:51 ET | 732 | 28.05 |
02:54 ET | 1747 | 28.095 |
02:56 ET | 500 | 28.08 |
02:58 ET | 900 | 28.0853 |
03:00 ET | 1193 | 28.1 |
03:02 ET | 3558 | 28.13 |
03:03 ET | 4902 | 28.095 |
03:05 ET | 900 | 28.1 |
03:09 ET | 1106 | 28.06 |
03:12 ET | 800 | 28.07 |
03:14 ET | 400 | 28.075 |
03:16 ET | 3100 | 28.08 |
03:18 ET | 1100 | 28 |
03:20 ET | 300 | 28.015 |
03:21 ET | 1429 | 27.9975 |
03:23 ET | 2200 | 28.02 |
03:25 ET | 1800 | 27.99 |
03:27 ET | 1300 | 27.99 |
03:30 ET | 400 | 27.995 |
03:32 ET | 1840 | 28.025 |
03:34 ET | 100 | 28.01 |
03:36 ET | 5728 | 27.95 |
03:38 ET | 911 | 27.955 |
03:39 ET | 1500 | 27.94 |
03:41 ET | 6074 | 27.94 |
03:43 ET | 3652 | 27.975 |
03:45 ET | 4963 | 27.88 |
03:48 ET | 4091 | 27.81 |
03:50 ET | 1695 | 27.8 |
03:52 ET | 4940 | 27.83 |
03:54 ET | 3809 | 27.85 |
03:56 ET | 6374 | 27.81 |
03:57 ET | 11808 | 27.955 |
03:59 ET | 180709 | 28.02 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Immunovant Inc | 4.3B | -14.6x | --- |
Crinetics Pharmaceuticals Inc | 4.3B | -13.5x | --- |
Avidity Biosciences Inc | 4.9B | -14.3x | --- |
BridgeBio Pharma Inc | 4.9B | -9.5x | --- |
Biohaven Ltd | 3.7B | -5.6x | --- |
Madrigal Pharmaceuticals Inc | 5.3B | -8.3x | --- |
Immunovant, Inc. is a clinical-stage immunology company. The Company is focused on developing treatments for patients with autoimmune diseases. Its product pipeline includes batoclimab and IMVT-1402, both of which are novel, fully human monoclonal antibodies that target the neonatal fragment crystallizable receptor (FcRn). Batoclimab is a subcutaneous injection with dosing. Batoclimab is observed to reduce immunoglobulin G (IgG) antibodies that cause inflammation and disease. Its product candidate, batoclimab, is dosed in small volumes and with a 27-gauge needle. It is developing batoclimab for myasthenia gravis (MG), thyroid eye disease (TED), chronic inflammatory demyelinating polyneuropathy (CIDP) and Graves’ disease (GD). Its lead product candidate IMVT-1402 has also been observed to reduce IgG antibody levels in a Phase I clinical trial conducted in healthy adults. IMVT-1402 is a fully human monoclonal antibody that inhibits FcRn.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $4.3B |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 146.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.71 |
EPS | $-1.92 |
Book Value | $4.24 |
P/E Ratio | -14.6x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.